ATC Group: J07AG01 Haemophilus influenzae B, purified antigen conjugated

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J07AG01 in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J07 Vaccines
3 J07A Bacterial vaccines
4 J07AG Haemophilus influenzae B vaccines
5 J07AG01 Haemophilus influenzae B, purified antigen conjugated

Active ingredients in J07AG01

Active Ingredient Description
Haemophilus influenzae B

Haemophilus influenza type B (Hib) is a bacteria responsible for severe pneumonia, meningitis and other invasive diseases almost exclusively in young children. Vaccines are the only public health tool capable of preventing the majority of serious Hib disease.

Medicines in this ATC group

Austria (AT)

Cyprus (CY)

Estonia (EE)

Finland (FI)

France (FR)

Hong Kong (HK)

Netherlands (NL)

New Zealand (NZ)

Poland (PL)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.